Inside the secretive and lucrative world of orchid breeding
The Hidden and Highly Profitable Realm of Orchid Cultivation
Creating a new orchid variety for the market is a marathon, not a sprint, often requiring ten years of rigorous effort. Although the global orchid industry is valued at hundreds of millions of dollars, offering substantial financial rewards, the rivalry to create the next stunning bloom is fierce. Consequently, in the quest to innovate, the laboratory has become just as critical as the greenhouse.
According to Floricultura, a prominent Dutch orchid breeding company, centuries of selective breeding and propagation by humans have rendered the genetic makeup of many commercial orchids a "disaster." This genetic complexity makes it incredibly challenging to forecast the traits of a new cultivar. To counter this, Floricultura and other industry players are utilizing genetic markers for specific attributes such as color, shape, disease resistance, and flowering duration to accelerate selective breeding. Rather than waiting three years for a newly bred plant to bloom, breeders can use genetic screening on young specimens early in the process to eliminate those that do not meet their criteria.
"If a few thousand cross breeds [come] from the lab, we can screen them based on the marker and just select the ones that have the marker that you search for," explains Wart van Zonneveld, Floricultura’s research and development manager. "It's an indication of a certain trait that you want or you do not want, depending on what's easier to find."
These so-called "novel breeding techniques" are closely guarded trade secrets. Each firm develops its own proprietary genetic markers and methods, as these innovations are key to producing unique varieties. "We keep it to ourselves because it's lots of investment," van Zonneveld notes.
Paul Arens, an ornamental plant breeding researcher at Wageningen University in the Netherlands, adds that the fundamental principles remain unchanged. "It's still breeding, you have to make a cross, and we cannot just pick out a piece of DNA and put it back that easily," he says. Arens and his team have contributed to a Dutch government-supported initiative that facilitates information sharing among participating companies. He explains that while the foundation remains the same as it was a century ago—selecting two plants with desired characteristics and crossing them—modern breeders now don white lab coats and employ genomics and marker research to assess plant health.
Genetics also play a pivotal role in safeguarding intellectual property rights for new varieties. In Europe, this is achieved through breeders' rights, while the United States utilizes patents. "If a company makes a new orchid, then [it] would like the sole right to commercialize this orchid," Arens states. "Otherwise, somebody else can just buy it in the shop, multiply it and sell it himself." To qualify for protection, a breeders' rights researcher must verify that a new variety is distinct, stable, and uniform compared to existing market offerings.
Although patents and breeders' rights are granted based on physical descriptions rather than DNA analysis, comparing new plants with similar products is essential to determine eligibility for protection. DNA analysis serves as a crucial tool in identifying which existing varieties the new cultivar should be compared against. "It's just like what we do in forensic science. You run markers that are at different positions in the DNA and that gives you a pattern and then you have a chance to match it or not," Arens says.
Floricultura does not sell directly to the public or garden centers. Instead, their business model focuses on developing and producing new varieties for large-scale cultivators. The company boasts over 180 varieties in its catalog, with several hundred more currently in development, driven by an unending demand for novelty. "You can't stop, because it takes so long to develop new varieties," says Stefan Kuiper, the company's breeding manager. "You have to go on, [or] you will be behind the times."
Source: BBC News Generated at: 2026-05-14 23:03:16 UTC

